StockData
IBACNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBACR

IB Acquisition Corp.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.86+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

IB Acquisition statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Commercial Physical & Biological Research companies for comparison

Valuation

MeasureIB AcquisitionIndustry median
Market Cap$54.39M$74.60M
Enterprise Value$54.36M$56.72M

Income (trailing twelve months)

MeasureIB AcquisitionIndustry median
Operating Income-$1.79M-$55.64K
Pretax Income-$171.66K$45.62K
Net Income-$399.57K-$97.64K
EBITDA-$1.79M-$29.48K

Returns

MeasureIB AcquisitionIndustry median
Return on Assets (ROA)-0.61%-3.47%

Growth

MeasureIB AcquisitionIndustry median
Net Income Growth (YoY)-111.1%-0.74%

Balance sheet

MeasureIB AcquisitionIndustry median
Cash & Short-Term Investments$30.16K$5.43M
Net Cash (Debt)$30.16K$17.62K
Net Cash Per Share$0.01$0.00
Equity (Book Value)-$2.31M$10.50M
Book Value Per Share-$0.46$0.60
Tangible Book Value-$2.31M-$78.36K

Cash flow (trailing twelve months)

MeasureIB AcquisitionIndustry median
Operating Cash Flow-$1.85M$8.04K

Dividends and yields

MeasureIB AcquisitionIndustry median
Earnings Yield-0.73%-0.97%

Shares

MeasureIB AcquisitionIndustry median
Shares Outstanding5,008,23029,217,800
Shares Change (QoQ)0.00%0.00%
Float3,770,35026,226,050
Shares Held by Insiders24.7%4.85%
Shares Held by Institutions114.3%83.3%

Taxes

MeasureIB AcquisitionIndustry median
Income Tax$227.91K$1.36M

Scores

MeasureIB AcquisitionIndustry median
Altman Z-Score12.262.66

Calculated by StockData from IB Acquisition's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.